Shanghai STAC Biotechnology prezante twa nouvo Rapid, gwo-Sensiblite AD Biomarker Kits

Apr 23, 2026 Kite yon mesaj

--Sipòte dyagnostik alzayme bonè ak konvenyans ak fyab

 

Shanghai, 23rd, avril 2026

 

Shanghai STAC Biotechnology Co, Ltd te lanse twa nouvo twous tès ki baze sou chimiluminesans pou dyagnostik oksilyè maladi alzayme a (AD). Ki fèt pou neroloji, jeryatrik, ak klinik memwa, twous sa yo ofri gwo sansiblite, gwo ranje lineyè, ak yon tan rapid tès 20 minit.

 

Avantaj kle nan twa twous yo

 

1. Twous P-Tau-181 (serom/Plasma)

Ultra-sansiblite segondè (mwens pase oswa egal a 1 pg/mL)

Lajè ranje lineyè (1-200 pg/mL)

Fyab (ekselan korelasyon ak metòd referans)

 

2. Yon Twous 1-42 (serom/Plasma)

Segondè sansiblite (mwens pase oswa egal a 5 pg/mL)

Ranje lineyè trè laj (5-500 pg/mL)

Bonjan pèfòmans analyse

 

3. AD7C-NTP Twous (pipi)

Ki pa-pwogrese – sèvi ak pipi olye pou yo san oswa CSF

Segondè sansiblite (mwens pase oswa egal a 0.2 ng/mL)

Korele ak severite bès kognitif - ideyal pou tès depistaj risk bonè

 

Avantaj Pataje

✅ Rezilta rapid nan 20 minit

✅ Segondè presizyon (CV mwens pase oswa egal a 8%)

✅ Sipòte dyagnostik AD, diferansyasyon demans, tès depistaj risk, ak siveyans maladi

✅ Konpatib ak analizeur kimiluminesans otomatik

 

Kontakte:
Shanghai STAC biotechnologie co, Ltd.
Imèl: stac@stacbio.com
WhatsApp: +86 13817316352
Sit entènèt: www.shanghaistac.com

Voye rechèch

whatsapp

Telefòn

Mel

Rechèch